Custom Health Holdings Inc. (TSX:CHLT) closed a public offering of 2,088,514 units at C$4.95 per unit, raising gross proceeds of C$10,338,144.30, according to a company press release issued today.
Each unit includes one common share and one warrant. Each warrant allows the holder to buy one common share at C$5.90 for 60 months. Stifel Nicolaus Canada Inc. served as lead agent and sole bookrunner.
The units were sold across Canada except Quebec, under a prospectus supplement dated November 11, 2026. The offering also included a private placement to accredited investors and qualified institutional buyers in the United States.
Shane Bishop, the company's Chief Executive Officer and a director, bought 282,830 units for C$1,400,008.50. The company said his purchase was a related party transaction under Multilateral Instrument 61-101. It said the company was exempt from formal valuation and minority shareholder approval requirements because the transaction value did not exceed 25% of its market capitalization.
The company said it will use the net proceeds for payments related to previously announced acquisitions and associated transaction costs, planned debt repayments, general and administrative expenses, and working capital.
The common shares have been listed on the Toronto Stock Exchange. The shares underlying the warrants and agent warrants received conditional TSX listing approval. The company said it will seek to list the warrants at a later date but gave no timing or guarantee of approval.
Custom Health describes itself as a digital health company that provides medication management services through in-home dispensing technology, remote monitoring, and pharmacist-led care.